ACM
LLY icon

Ascent Capital Management’s Eli Lilly LLY Stock Holding History

Ascent Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$398K Buy
521
+28
+6% +$20.8K 0.32% 38
2025
Q2 		$385K Sell
493
-2
-0.4% -$1.55K 0.34% 37
2025
Q1 		$409K Buy
495
+12
+2% +$9.98K 0.41% 35
2024
Q4 		$373K Buy
+483
New +$400K 0.38% 35

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ascent Capital Management's LLY Position: Q3 2025 in Review

Ascent Capital Management increased its Eli Lilly (LLY) stake by 5.7% in Q3 2025, buying an estimated $20.8K and bringing the position to 521 shares worth $398K. The position accounts for 0.32% of the portfolio, ranked #38.

Ascent Capital Management first reported a position in LLY in Q4 2024 and has held it in 4 quarters since. The position peaked at $409K in Q1 2025. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Ascent Capital Management held 521 shares of Eli Lilly worth $398K as of Q3 2025.
  • Ascent Capital Management bought 28 Eli Lilly shares in Q3 2025, an estimated $20.8K.
  • Eli Lilly made up 0.32% of Ascent Capital Management's portfolio in Q3 2025, its #38 holding.
  • Ascent Capital Management first reported a position in Eli Lilly in Q4 2024 and has held it in 4 quarters since.
  • Ascent Capital Management's Eli Lilly position peaked at $409K in Q1 2025.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Ascent Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.